Physician profile
Eugene Dula
NPI 1184694523
$8,492.25
in general payments reported to CMS, 2019-2025
34 companies · $578 in 2025
The $578 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $3,214 · 2021: $740 · 2022: $1,170 · 2023: $773 · 2024: $865 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,215.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,721.19 | 2019-2020 | |
| Pfizer INC. | $601.24 | 2019-2025 | |
| Blue Earth Diagnostics | $439.46 | 2021-2025 | Posluma |
| Coloplast Corp | $396.63 | 2019-2023 | Speedicath |
| Procept Biorobotics Corporation | $376.00 | 2021-2023 | Aquabeam Robotic System |
| Rochester Medical Corporation | $326.36 | 2022 | |
| Endo Pharmaceuticals INC. | $319.47 | 2020-2024 | Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $316.84 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter, Magic3 Intermittent Catheter |
| Abbvie INC. | $263.43 | 2019-2025 | Lupron Depot |
| Astellas Pharma US INC | $220.60 | 2019-2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $190.44 | 2021-2024 | Prolaris |
| Janssen Biotech, INC. | $161.15 | 2019-2023 | Erleada |
| Progenics Pharmaceuticals, INC. | $125.57 | 2022-2025 | Pylarify |
| Antares Pharma, INC. | $111.29 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Profound Medical Corp. | $99.57 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $98.87 | 2024 | Xiaflex, Aveed |
| Teleflex LLC | $85.48 | 2025 | Barrigel |
| Telix Pharmaceuticals | $78.44 | 2025 | Illuccix |
| Becton, Dickinson and Company | $64.18 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $61.87 | 2023-2024 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $53.79 | 2019-2024 | Ams Ambicor |
| Dendreon Pharmaceuticals LLC | $47.95 | 2019 | |
| Olympus America INC. | $47.52 | 2020-2023 | Itind System |
| Myovant Sciences INC. | $43.28 | 2021-2022 | |
| Accord Healthcare, INC. | $42.12 | 2024 | |
| Urogen Pharma, INC. | $38.76 | 2022-2023 | Jelmyto |
| Bard Access Systems, INC. | $26.25 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $24.89 | 2021 | |
| Amgen INC. | $23.64 | 2023 | Prolia |
| Metuchen Pharmaceuticals | $20.17 | 2020 | |
| Axonics, INC. | $19.74 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $18.45 | 2019 | |
| Abc Home Medical Supply, INC. | $14.60 | 2022 | |
| Tolmar, INC. | $13.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Dula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.